+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

B-Cell Non-Hodgkin Lymphoma (NHL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma (NHL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • January 2023
  • 123 Pages
  • Global
From
Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • January 2023
  • 97 Pages
  • Global
From
Bile Duct Cancer (Cholangiocarcinoma) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • November 2022
  • 82 Pages
  • Global
From
Bladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Bladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • November 2022
  • 1018 Pages
  • Global
From
Non-Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Non-Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • November 2022
  • 164 Pages
  • Global
From
Esophageal Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Esophageal Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • October 2022
  • 73 Pages
  • Global
From
Nasopharyngeal Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Nasopharyngeal Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • July 2022
  • 521 Pages
  • Global
From
Waldenstrom Macroglobulinemia (WM) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Waldenstrom Macroglobulinemia (WM) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • June 2022
  • 65 Pages
  • Global
From
Colorectal Cancer Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Colorectal Cancer Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • June 2022
  • 53 Pages
  • Global
From
Metastatic Melanoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Metastatic Melanoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • June 2022
  • 946 Pages
  • Global
From
Neuroendocrine Tumors Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Neuroendocrine Tumors Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • May 2022
  • 76 Pages
  • Global
From
Immuno-Oncology - Thematic Research - Product Thumbnail Image

Immuno-Oncology - Thematic Research

  • Report
  • May 2022
  • 167 Pages
  • Global
From
Gastric and Gastroesophageal Junction Adenocarcinoma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029 - Product Thumbnail Image

Gastric and Gastroesophageal Junction Adenocarcinoma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029

  • Drug Pipelines
  • May 2022
  • 138 Pages
  • Global
From
Pancreatic Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update - Product Thumbnail Image

Pancreatic Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update

  • Report
  • April 2022
  • 79 Pages
  • Global
From
Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update - Product Thumbnail Image

Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update

  • Report
  • April 2022
  • 71 Pages
  • Global
From
Osteosarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027 - Product Thumbnail Image

Osteosarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027

  • Report
  • March 2022
  • 41 Pages
  • Global
From
Cervical Cancer - Epidemiology Forecast to 2030 - Product Thumbnail Image

Cervical Cancer - Epidemiology Forecast to 2030

  • Report
  • January 2022
  • 41 Pages
  • Global
From
Contract Small Molecule API Manufacturing Industry by the Numbers - 2021 Edition - Product Thumbnail Image

Contract Small Molecule API Manufacturing Industry by the Numbers - 2021 Edition

  • Report
  • December 2021
  • 53 Pages
  • Global
From
Head and Neck Squamous Cell Carcinoma - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Head and Neck Squamous Cell Carcinoma - Global Drug Forecast and Market Analysis to 2030

  • Report
  • October 2021
  • 131 Pages
  • Global
From
Neuroendocrine Tumors - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Neuroendocrine Tumors - Global Drug Forecast and Market Analysis to 2030

  • Report
  • September 2021
  • 126 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more